Clinical Trial Update: Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trials evaluated autologous tissue repair cell therapy from Aastrom Biosciences for treating alveolar bone defects related to periodont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Aastrom Autologous Tissue Repair Cell Therapy

Snippet

Sponsor: University of Michigan | Conditions: Alveolar Bone Loss | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-15